Novartis’s ‘Poster Child’ Zolgensma Shows What Gene Therapy Can Do – And Its Limitations

Long-Term Data Brings Hope To Rare Disease Communities

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.